Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways. - Wikidata - awgldk - TriplyDB

Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.

Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.

http://www.wikidata.org/entity/Q30435726

about

What's new in estrogen receptor action in the female reproductive tract Insulin-like growth factor and epidermal growth factor signaling in breast cancer cell growth: focus on endocrine resistant disease Phenobarbital induces alterations in the proteome of hepatocytes and mesenchymal cells of rat livers 17ß-Estradiol regulates mTORC2 sensitivity to rapamycin in adaptive cardiac remodeling A mechanistic study of the effect of doxorubicin/adriamycin on the estrogen response in a breast cancer model RSK in tumorigenesis: connections to steroid signaling.Functional interactions between 17 β -estradiol and progesterone regulate autophagy during acini formation by bovine mammary epithelial cells in 3D cultures Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia.Ecdysone and the cell cycle: investigations in a mosquito cell line.The contribution of 17beta-hydroxysteroid dehydrogenase type 1 to the estradiol-estrone ratio in estrogen-sensitive breast cancer cells Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta.The role of adiponectin in cancer: a review of current evidence.Src-dependent phosphorylation at Y406 on the thyroid hormone receptor β confers the tumor suppressor activity Lactogens and estrogens in breast cancer chemoresistance.Adaptive changes result in activation of alternate signaling pathways and acquisition of resistance to aromatase inhibitors Epidermal growth factor receptor gene polymorphisms are associated with prognostic features of breast cancer LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.Distinct transcriptional regulation of human large conductance voltage- and calcium-activated K+ channel gene (hSlo1) by activated estrogen receptor alpha and c-Src tyrosine kinase Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1).Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen Proliferation of human mammary cancer cells exposed to 27-hydroxycholesterol Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo.Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence.RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptor Estrogen deficiency reversibly induces telomere shortening in mouse granulosa cells and ovarian aging in vivo Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved Extranuclear signaling by estrogen: role in breast cancer progression and metastasis.Mediator of ERBB2-driven cell motility (MEMO) promotes extranuclear estrogen receptor signaling involving the growth factor receptors IGF1R and ERBB2 PDZK1 is a novel factor in breast cancer that is indirectly regulated by estrogen through IGF-1R and promotes estrogen-mediated growth.Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications.Molecular mechanisms of gonadotropin-releasing hormone signaling: integrating cyclic nucleotides into the network.The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules Effects of 17β-estradiol and tamoxifen on gastric cancer cell proliferation and apoptosis and ER-α36 expression Extra-nuclear effects of estrogen on cortical bone in males require ERαAF-1.Finding biomarkers in non-model species: literature mining of transcription factors involved in bovine embryo development.The Role of Cholesterol in Cancer.

P2860

Q26772956-3D79B146-CE00-4F8A-86F9-5D043C51BA2C Q26800001-D7BDEE25-FF54-437B-AC30-D3597148A0A7 Q27304855-1D15A2A5-6D4C-489E-A027-7D5F701A03D6 Q28546463-F7696ED4-AFCE-49F1-9BF2-F22E8F270D47 Q30417300-8AC5A768-9ACC-4462-869F-E0837585CC42 Q30433106-2A565BFC-0BA1-43D4-82B4-69EBAA8554CF Q33660438-83FD78D7-7220-42C9-A681-A3A641D616EE Q33857846-5AB11E0C-C850-4919-81CC-7BA20895B978 Q34054117-83BA8617-B52E-4245-A101-A0485D888B39 Q34130698-A6E4CB38-C1FE-4EFD-ABEB-09558505616C Q34157563-B4AC8C2E-51FA-493A-AD02-73F4047B9B15 Q34271986-72847666-FF60-4D21-81EF-B51516F49776 Q34654368-416F5ADB-6471-4CB1-90DE-4D5539BB95E2 Q35075176-A7F7D91C-AA0B-4934-93D2-EF8997D45AED Q35091502-4FF6E327-9CEE-4B0A-9741-A0566AABF2CC Q35120828-33467E73-8A6F-4973-A9D3-450E26B46F23 Q35145443-D329F855-1872-462A-BDCE-876F4A828751 Q35157919-0ED17910-AF99-4091-8490-9DF28B361B88 Q35213206-AC8A7BA0-BDD0-4EA6-A10F-557F732E3D53 Q35218145-00D23341-D5D0-43E5-B607-F2D9A33F3332 Q35604651-71FA056E-1D34-4443-9FAA-F8BC77FFF350 Q35683515-E14C836D-BE81-4516-A27D-560BB14E73CF Q36059078-78A05075-1773-447E-BC00-3E7DDD7E6A1A Q36244059-75710832-C1F7-44B0-BC31-AA0846635D20 Q36245457-AF08DCAD-4101-4F92-9910-4FF12A776977 Q36418331-5269888B-3DE2-4DD1-89D7-6483151932D9 Q36903427-4DB66C1E-A13D-4262-9596-48A9C6C3083F Q36922713-43A0AD28-7C09-4F5B-AD56-2B8F24614B9A Q36946008-1AF173DF-3770-4C28-950E-DAEDDF68204D Q37060140-4C5109BA-F229-41E2-93CA-FEB86C9A8A08 Q37112684-B2B6DA30-1326-4ED8-973F-4255E9D333A8 Q37161525-C2D8751E-4915-45CE-91FF-44D0844FECE8 Q37255088-40768C5C-705C-4161-ADBC-BC752C745283 Q37326059-22BF951E-CCEC-41D5-8BAB-8BDC5F055EC8 Q37481267-0B6E7363-DC54-464E-A7FF-6D4342CFDAAA Q37581720-E1B2AAAF-88C4-4CA5-88BB-C7F00BC15F31 Q37594019-1D4FCC88-9FA7-41BB-8D82-641325AB31CE Q37612772-5F562560-9CD1-4026-BBED-B4A43BE85BB2 Q38495373-14956807-6E5B-46A7-93CE-1EDD31971372 Q38838555-FD738321-4F0F-4765-8053-B74601198A59

P2860

Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.

http://www.wikidata.org/entity/Q30435726

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Novel actions of estrogen to p ...... oplasmic and nuclear pathways.

@ast

Novel actions of estrogen to p ...... oplasmic and nuclear pathways.

@en

type

label

Novel actions of estrogen to p ...... oplasmic and nuclear pathways.

@ast

Novel actions of estrogen to p ...... oplasmic and nuclear pathways.

@en

prefLabel

Novel actions of estrogen to p ...... oplasmic and nuclear pathways.

@ast

Novel actions of estrogen to p ...... oplasmic and nuclear pathways.

@en

P1433

Q30435726-B192065B-1A84-4033-8D1C-74B9947C9DA9

P1476

Q30435726-C775227A-8AA9-4B25-8D1F-151410BE9704

P2093

Q30435726-7A2B382E-CF81-480C-A665-76E9F221605D

Q30435726-87EBB4B6-1F47-4CBA-B496-76DF198051E4

Q30435726-D9F733A9-0BC4-4C4B-838D-3FC0712B46FA

P2860

Q30435726-02E5BE3C-1CA3-47D4-AEB1-31489E0202CD

Q30435726-0375A29B-07E6-4270-B11A-700B8AFCD4D1

Q30435726-05542E8F-AEEB-49A3-8C54-9EE5A71B9677

Q30435726-1303ADAE-FBD6-4614-8268-F6D0366D7FA6

Q30435726-14EAA21E-9B1C-42D9-8700-D6E1DCDEC9F1

Q30435726-2028CAB7-3A1A-46A8-9B03-8002D83D79CC

Q30435726-268904AA-108C-4D51-B534-79FDBECCB625

Q30435726-28942122-D990-45F6-9F88-20E44C948BAF

Q30435726-383D4028-98C7-4E15-87D6-47AC0FB035D7

Q30435726-3B82BA62-7F49-4477-B0C0-B23A7CC169AB

P304

Q30435726-6B699556-17E8-448F-8A37-566ABCE9B86A

P31

Q30435726-FB9851DD-457B-4C6C-A003-39E544624736

P356

Q30435726-576726F9-213B-4DB4-B0E9-04DEEBF6D616

P433

Q30435726-B4D2AA43-3C36-439F-8E72-BF14A7AF93B3

P478

Q30435726-BB324BA9-5617-43FE-8643-6AA2BCAC0E31

P577

Q30435726-5AA8E60D-6C4E-4C16-82C1-E5C24FB0BCDB

P698

Q30435726-1AB1A840-385C-40E2-B7DA-7BFBFD7ACFB5

P932

Q30435726-CCE2DE1A-2BFD-4DBD-8061-E71875641E00

P356

J.STEROIDS.2008.10.014

P1433

P1476

Novel actions of estrogen to p ...... oplasmic and nuclear pathways.

@en

P2093

Emily M Fox

http://www.w3.org/2001/XMLSchema#string

Josefa Andrade

http://www.w3.org/2001/XMLSchema#string

Margaret A Shupnik

http://www.w3.org/2001/XMLSchema#string

P2860

Epidermal growth factor directs sex-specific steroid signaling through Src activation

Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer

leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3

Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation

Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription

The STATs of cancer--new molecular targets come of age

c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function.

STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor.

The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane.

Src family kinases, key regulators of signal transduction.

P304

622-627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.STEROIDS.2008.10.014

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18996136

http://www.w3.org/2001/XMLSchema#string

P932

2702758

http://www.w3.org/2001/XMLSchema#string